Ovid Therapeutics (OVID) EBITDA (2016 - 2026)
Ovid Therapeutics (OVID) posted EBITDA of -$15.68 million for Q2 2026, compared with -$4.97 million a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) EBITDA (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Ovid Therapeutics was -$58.28 million; for FY2025, it was -$42.17 million.
- In prior years, Ovid Therapeutics' EBITDA was -$61.27 million in FY2024, -$58.71 million in FY2023, -$55.04 million in FY2022 and $124.45 million in FY2021.
- Quarterly EBITDA has run from a low of -$26.3 million in Q4 2021 to a high of -$4.97 million in Q2 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$17.81 million (Q1 2026), -$12.28 million (Q4 2025) and -$12.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.42 Bn | 1,103.01 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.36 Bn | 537.89 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.11 Bn | 483.22 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.37 Bn | 319.75 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.64 Bn | 261.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 262.52 Bn | 236.21 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.62 Bn | 192.02 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 192.60 Bn | 166.80 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.88 Bn | 117.53 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ovid Therapeutics | 467.96 Mn | 99.99 Mn | - | -15.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.68 Mn |
| Mar 31, 2026 | -17.81 Mn |
| Dec 31, 2025 | -12.28 Mn |
| Sep 30, 2025 | -12.51 Mn |
| Jun 30, 2025 | -4.97 Mn |
| Mar 31, 2025 | -12.41 Mn |
| Dec 31, 2024 | -10.56 Mn |
| Sep 30, 2024 | -13.06 Mn |
| Jun 30, 2024 | -20.37 Mn |
| Mar 31, 2024 | -17.28 Mn |
| Dec 31, 2023 | -18.05 Mn |
| Sep 30, 2023 | -11.88 Mn |
| Jun 30, 2023 | -14.04 Mn |
| Mar 31, 2023 | -14.75 Mn |
| Dec 31, 2022 | -11.99 Mn |
| Sep 30, 2022 | -12.65 Mn |
| Jun 30, 2022 | -14.21 Mn |
| Mar 31, 2022 | -16.19 Mn |
| Dec 31, 2021 | -26.30 Mn |
| Sep 30, 2021 | -11.63 Mn |
API Access
Ovid Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();